Controversy arises over introduction of drug utilization review system next year

Published: 2003-12-08 07:00:00

Updated: 2003-12-08 07:00:00

The government unveiled a plan to implement a new drug utilization review (DUR) system designed to check the prescription of contraindicated drugs and/or drugs prohibiting the use beyond specific age groups next year but its earlier introduction has been controversial due to opposition from medic...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK